Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society, Eur Heart J. 1 déc, vol.34, issue.45, pp.3478-90, 2013. ,
The genetics and screening of familial hypercholesterolaemia, J Biomed Sci, vol.23, issue.1 ,
The practice guideline 'Diagnosis and treatment of familial hypercholesterolaemia' of the Dutch Health Care Insurance Board ,
, Ned Tijdschr Geneeskd, vol.150, pp.18-23, 2006.
Clinical characteristics and evaluation of LDLcholesterol treatment of the Spanish Familial Hypercholesterolemia Longitudinal Cohort Study (SAFEHEART), Lipids Health Dis, vol.10, p.94, 2011. ,
, Scientific Steering Committee on behalf of the Simon Broome Register Group. Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical management, Atherosclerosis, vol.142, pp.105-112, 1999.
Familial hypercholesterolemia in the danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication, J Clin Endocrinol Metab, vol.97, issue.11, pp.3956-64, 2012. ,
Efficacy of statins in familial hypercholesterolaemia: a long term cohort study, BMJ, vol.337, p.2423, 2008. ,
20-Year Follow-up of Statins in Children with Familial Hypercholesterolemia, N Engl J Med, vol.381, pp.1547-1556, 2019. ,
, Diagnostic et traitement des hypercholestérolémies familiales (HF) chez l'adulte : recommandations de la Nouvelle société française d'athérosclérose (NSFA)
The origins of the developmental origins theory, J Intern Med, 2007. ,
Effects of prenatal exposure to the Dutch famine on adult disease in later life: an overview, Mol Cell Endocrinol, vol.185, issue.1-2, pp.93-101, 2001. ,
Per Ole Iversen a, Marked changes in plasma lipids and lipoproteins during pregnancy in women with familial hypercholesterolemia, Atherosclerosis, vol.189, pp.451-457, 2006. ,
Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk, The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and ,
,
Alexandre Vimont, Sybil Charrière, Eric Bruckert, French FH Registry group, High burden of recurrent cardiovascular events in heterozygous familial hypercholesterolemia: The French Familial Hypercholesterolemia Registry, Atherosclerosis, vol.277, pp.334-340, 2018. ,
,
,
Dyslipidemia of Mothers With Familial Hypercholesterolemia Deteriorates Lipids in Adult Offspring, Arterioscler Thromb Vasc Biol, vol.30, pp.2673-2677, 2010. ,
,
Kjetil Retterstøl, Kirsten B. Holven, Maternal inheritance does not predict cholesterol levels in children with familial hypercholesterolemia, Atherosclerosis, vol.243, pp.155-160, 2015. ,
,
Inheritance pattern of familial hypercholesterolemia and markers of cardiovascular risk, J. Lipid Res, vol.54, pp.2543-2549, 2013. ,
Maternal inheritance of familial hypercholesterolemia caused by the V408M low-density lipoprotein receptor mutation increases mortality, Atherosclerosis, vol.219, pp.690-693, 2011. ,
Influence of maternal hypercholesterolaemia during pregnancy on progression of early atherosclerotic lesions in 25 childhood: Fate of Early Lesions in Children (FELIC) study, THE LANCET ·, vol.354, 1999. ,
,
Fatty Streak Formation Occurs in Human Fetal Aortas and is Greatly Enhanced by Maternal Hypercholesterolemia, J Clin Invest, vol.100, issue.11, pp.2680-2690, 1997. ,
Maternal Hypercholesterolemia and Treatment During Pregnancy Influence the Long-Term Progression of Atherosclerosis in Offspring of Rabbits, Circ Res, vol.89, pp.991-996, 2001. ,
,
,
Maternal Hypercholesterolemia During Pregnancy Promotes Early Atherogenesis in LDL Receptor-Deficient Mice and Alters Aortic Gene Expression Determined by Microarray, Circulation, vol.105, pp.1360-1367, 2002. ,
,
Short-Term Exposure to Exogenous Lipids in Premature Infants and Long-Term Changes in Aortic and Cardiac Function, Arterioscler Thromb Vasc Biol, vol.31, pp.2125-2135, 2011. ,
The Good, the Bad, and the Ugly of Pregnancy Nutrients and Developmental Programming of Adult Disease, Nutrients, 2019. ,
Perinatal Hypercholesterolemia Exacerbates Atherosclerosis Lesions in Offspring by Altering Metabolism of Trimethylamine-N-Oxide and Bile Acids, Arterioscler Thromb Vasc Biol, vol.37, pp.2053-2063, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-02429561
Circulating trimethylamine N-oxide and the risk of cardiovascular diseases: a systematic review and metaanalysis of 11 prospective cohort studies, J. Cell. Mol. Med, vol.22, issue.1, pp.185-194, 2018. ,
,
,
Trimethylamine-N-Oxide, a Metabolite Associated with Atherosclerosis, Exhibits Complex Genetic and Dietary Regulation, Cell Metab ,
, January, vol.8, issue.1, pp.49-60
A rare missense variant in NR1H4 associates with lower cholesterol levels, Commun Biol, vol.1, p.14, 2018. ,
Phosphorylation of hepatic farnesoid X receptor by FGF19 signaling-activated Src maintains cholesterol levels and protects from atherosclerosis, J. Biol. Chem, 2019. ,
for the Bogalusa Heart Study. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults, N Engl J Med, vol.338, pp.1650-1656, 1998. ,
Lipoprotein(a) as a cardiovascular risk factor: current status, European heart journal ,
URL : https://hal.archives-ouvertes.fr/inserm-00578888
,
,
,
,
Lipoprotein(a) and the risk of cardiovascular disease in the European population: results from the BiomarCaRE consortium, European Heart Journal, vol.38, pp.2490-2498, 2017. ,